147 related articles for article (PubMed ID: 25676533)
1. Piceatannol inhibits effector T cell functions by suppressing TcR signaling.
Kim DH; Lee YG; Park HJ; Lee JA; Kim HJ; Hwang JK; Choi JM
Int Immunopharmacol; 2015 Apr; 25(2):285-92. PubMed ID: 25676533
[TBL] [Abstract][Full Text] [Related]
2. Rottlerin inhibits human T cell responses.
Springael C; Thomas S; Rahmouni S; Vandamme A; Goldman M; Willems F; Vosters O
Biochem Pharmacol; 2007 Feb; 73(4):515-25. PubMed ID: 17141738
[TBL] [Abstract][Full Text] [Related]
3. The role of tumor cells in the modification of T lymphocytes activity--the expression of the early CD69+, CD71+ and the late CD25+, CD26+, HLA/DR+ activation markers on T CD4+ and CD8+ cells in squamous cell laryngeal carcinoma. Part I.
Starska K; Głowacka E; Kulig A; Lewy-Trenda I; Bryś M; Lewkowicz P
Folia Histochem Cytobiol; 2011; 49(4):579-92. PubMed ID: 22252752
[TBL] [Abstract][Full Text] [Related]
4. Costunolide, a sesquiterpene lactone, inhibits the differentiation of pro-inflammatory CD4
Park E; Song JH; Kim MS; Park SH; Kim TS
Int Immunopharmacol; 2016 Nov; 40():508-516. PubMed ID: 27756053
[TBL] [Abstract][Full Text] [Related]
5. Prognostic value of the immunological phenomena and relationship with clinicopathological characteristics of the tumor--the expression of the early CD69+, CD71+ and the late CD25+, CD26+, HLA/DR+ activation markers on T CD4+ and CD8+ lymphocytes in squamous cell laryngeal carcinoma. Part II.
Starska K; Głowacka E; Kulig A; Lewy-Trenda I; Bryś M; Lewkowicz P
Folia Histochem Cytobiol; 2011; 49(4):593-603. PubMed ID: 22252753
[TBL] [Abstract][Full Text] [Related]
6. Glt25d2 Knockout Directly Increases CD25+CD69- but Decreases CD25-CD69+ Subset Proliferation and is Involved in Concanavalin-Induced Hepatitis.
Hao X; Liu R; Zhang Y; Li Y; He Q; Huang Y; Jiang Y; Ma J; Li P; Wei H
Cell Physiol Biochem; 2018; 50(3):1186-1200. PubMed ID: 30355948
[TBL] [Abstract][Full Text] [Related]
7. Exogenous immunoglobulin downregulates T-cell receptor signaling and cytokine production.
Tawfik DS; Cowan KR; Walsh AM; Hamilton WS; Goldman FD
Pediatr Allergy Immunol; 2012 Feb; 23(1):88-95. PubMed ID: 21265884
[TBL] [Abstract][Full Text] [Related]
8. Differential alterations of tissue T-cell subsets after sepsis.
Sharma A; Yang WL; Matsuo S; Wang P
Immunol Lett; 2015 Nov; 168(1):41-50. PubMed ID: 26362089
[TBL] [Abstract][Full Text] [Related]
9. D-Limonene modulates T lymphocyte activity and viability.
Lappas CM; Lappas NT
Cell Immunol; 2012 Sep; 279(1):30-41. PubMed ID: 23059811
[TBL] [Abstract][Full Text] [Related]
10. IRF2BP2 transcriptional repressor restrains naive CD4 T cell activation and clonal expansion induced by TCR triggering.
Sécca C; Faget DV; Hanschke SC; Carneiro MS; Bonamino MH; de-Araujo-Souza PS; Viola JP
J Leukoc Biol; 2016 Nov; 100(5):1081-1091. PubMed ID: 27286791
[TBL] [Abstract][Full Text] [Related]
11. Artesunate inhibits proliferation of naïve CD4(+) T cells but enhances function of effector T cells.
Lee SH; Cho YC; Kim KH; Lee IS; Choi HJ; Kang BY
Arch Pharm Res; 2015 Jun; 38(6):1195-203. PubMed ID: 25370606
[TBL] [Abstract][Full Text] [Related]
12. Sodium arsenite-induced inhibition of cell proliferation is related to inhibition of IL-2 mRNA expression in mouse activated T cells.
Conde P; Acosta-Saavedra LC; Goytia-Acevedo RC; Calderon-Aranda ES
Arch Toxicol; 2007 Apr; 81(4):251-9. PubMed ID: 17009048
[TBL] [Abstract][Full Text] [Related]
13. In-vitro generation and characterisation of murine CD4+CD25+ regulatory T cells with indirect allospecificity.
Tsang J; Jiang S; Tanriver Y; Leung E; Lombardi G; Lechler RI
Int Immunopharmacol; 2006 Dec; 6(13-14):1883-8. PubMed ID: 17161341
[TBL] [Abstract][Full Text] [Related]
14. A humanised therapeutic CD4 mAb inhibits TCR-induced IL-2, IL-4, and IL-10 secretion and expression of CD25, CD40L, and CD69.
Woods M; Guy R; Waldmann H; Glennie M; Alexander DR
Cell Immunol; 1998 May; 185(2):101-13. PubMed ID: 9636688
[TBL] [Abstract][Full Text] [Related]
15. T cells in sputum of asthmatic patients are activated independently of disease severity or control.
Lourenço O; Mafalda Fonseca A; Taborda-Barata L
Allergol Immunopathol (Madr); 2009; 37(6):285-92. PubMed ID: 19850398
[TBL] [Abstract][Full Text] [Related]
16. Plasticity of the murine spleen T-cell cholinergic receptors and their role in in vitro differentiation of naïve CD4 T cells toward the Th1, Th2 and Th17 lineages.
Qian J; Galitovskiy V; Chernyavsky AI; Marchenko S; Grando SA
Genes Immun; 2011 Apr; 12(3):222-30. PubMed ID: 21270829
[TBL] [Abstract][Full Text] [Related]
17. Induction of granzyme B and T cell cytotoxic capacity by IL-2 or IL-15 without antigens: multiclonal responses that are extremely lytic if triggered and short-lived after cytokine withdrawal.
Tamang DL; Redelman D; Alves BN; Vollger L; Bethley C; Hudig D
Cytokine; 2006 Nov; 36(3-4):148-59. PubMed ID: 17188506
[TBL] [Abstract][Full Text] [Related]
18. miR-20a inhibits TCR-mediated signaling and cytokine production in human naïve CD4+ T cells.
Reddycherla AV; Meinert I; Reinhold A; Reinhold D; Schraven B; Simeoni L
PLoS One; 2015; 10(4):e0125311. PubMed ID: 25884400
[TBL] [Abstract][Full Text] [Related]
19. Pancreatic cancer alters human CD4+ T lymphocyte function: a piece in the immune evasion puzzle.
Fogar P; Basso D; Fadi E; Greco E; Pantano G; Padoan A; Bozzato D; Facco M; Sanzari MC; Teolato S; Zambon CF; Navaglia F; Semenzato G; Pedrazzoli S; Plebani M
Pancreas; 2011 Oct; 40(7):1131-7. PubMed ID: 21792088
[TBL] [Abstract][Full Text] [Related]
20. [Effect of resveratrol on the activation of murine CD4(+);T lymphocytes].
Wang Z; Zeng X; Li M; Luo X
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2013 Jul; 29(7):677-80. PubMed ID: 23837973
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
